Jeff Tarr is the CEO of Solera Holdings, Inc. He joined the company following more than two decades of experience leading data and technology-enabled services companies across multiple sectors.
Jeff has a proven track record of transformational leadership, instilling a purpose-driven culture with a customer-centered approach that drives growth and value for the companies he leads and the customers he serves. Jeff believes in the power of team, and invests in his employees, creating an environment that empowers each individual to do his or her best work.
Prior to joining Solera, Jeff was CEO of the publicly-traded company DigitalGlobe, the world leader in satellite imagery and geospatial intelligence. There he led the company as it launched innovative products employing AI and other new technologies, entered new markets, and nearly tripled its revenue. Prior to DigitalGlobe Jeff was President & COO of IHS (now IHS Markit).
Jeff received his bachelor’s degree from Princeton University’s Woodrow Wilson School of Public and International Affairs, and an MBA from the Stanford Graduate School of Business. He serves on numerous corporate and philanthropic boards, including as a member of the board of EchoStar (NASDAQ: SATS), Chairman of the Stanford Graduate School of Business Management Board, Co-Chairman of the World Economic Forum’s Council on the Future of Space Technologies, and a member of the Council on Foreign Relations.
Chief Administrative Officer, General Counsel & Corporate Secretary
Prior to joining the Company in March 2008, Jason Brady provided legal consulting services to technology and entertainment organizations. Before that, he was Vice President, General Counsel and Corporate Secretary of biotechnology firm Xenogen Corporation. Brady represented Xenogen in its business defamation and patent infringement litigation with AntiCancer as well as its $80 million acquisition by Caliper Life Sciences, Inc.
As the Director of Legal Affairs for Abbott Diabetes Care, the diabetes testing device division of Abbott Laboratories, Mr. Brady oversaw domestic legal operations. He also worked as Director of Legal Affairs for TheraSense, Inc., a manufacturer of blood glucose monitoring systems. At TheraSense, Brady represented the company during its $131 million initial public offering and its $1.25 billion acquisition by Abbott Laboratories.
Prior to TheraSense, Brady was the General Counsel for Ensera, Inc., a provider of auto collision claims processing software, and Deputy General Counsel for AllAdvantage, a data management company.
At Ensera, he gained valuable insight into the software and services segment of the claims processing industry. During his tenure there he worked closely with Tony Aquila, to build the business as a member of the organization’s senior management team.
Mr. Brady started his career as an associate at Wilson Sonsini Goodrich & Rosati, P.C. He received a B.A. in History from the University of California Los Angeles, and his J.D. from Santa Clara University School of Law.